-
1
-
-
23944526062
-
Activation of AKT kinases in cancer: Implications for therapeutic targeting
-
DOI 10.1016/S0065-230X(05)94002-5, PII S0065230X05940025
-
Bellacosa, A., Kumar, C. C., Di Cristofano, A., and Testa, J. R. (2005) Activation of AKT kinases in cancer: implications for therapeutic targeting Adv. Cancer Res. 94, 29-86 (Pubitemid 41202364)
-
(2005)
Advances in Cancer Research
, vol.94
, Issue.1 SUPPL.
, pp. 29-86
-
-
Bellacosa, A.1
Kumar, C.C.2
Cristofano, A.D.3
Testa, J.R.4
-
2
-
-
0033517190
-
NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling
-
Romashkova, J. A. and Makarov, S. S. (1999) NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling Nature 401, 86-90
-
(1999)
Nature
, vol.401
, pp. 86-90
-
-
Romashkova, J.A.1
Makarov, S.S.2
-
3
-
-
0001582482
-
Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: Amplification of AKT1 in a primary human gastric adenocarcinoma
-
DOI 10.1073/pnas.84.14.5034
-
Staal, S. P. (1987) Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma Proc. Natl. Acad. Sci. U.S.A. 84, 5034-5037 (Pubitemid 17095859)
-
(1987)
Proceedings of the National Academy of Sciences of the United States of America
, vol.84
, Issue.14
, pp. 5034-5037
-
-
Staal, S.P.1
-
4
-
-
0034742120
-
AKT1/PKBα kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells
-
Sun, M., Wang, G., Paciga, J. E., Feldman, R. I., Yuan, Z. Q., Ma, X. L., Shelley, S. A., Jove, R., Tsichlis, P. N., Nicosia, S. V., and Cheng, J. Q. (2001) AKT1/PKBalpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells Am. J. Pathol. 159, 431-437 (Pubitemid 32751073)
-
(2001)
American Journal of Pathology
, vol.159
, Issue.2
, pp. 431-437
-
-
Sun, M.1
Wang, G.2
Paciga, J.E.3
Feldman, R.I.4
Yuan, Z.-Q.5
Ma, X.-L.6
Shelley, S.A.7
Jove, R.8
Tsichlis, P.N.9
Nicosia, S.V.10
Cheng, J.Q.11
-
5
-
-
0029127042
-
Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas
-
Bellacosa, A., de Feo, D., Godwin, A. K., Bell, D. W., Cheng, J. Q., Altomare, D. A., Wan, M., Dubeau, L., Scambia, G., Masciullo, V., Ferrandina, G., Benedetti Panici, P., Mancuso, S., Neri, G., and Testa, J. R. (1995) Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas Int. J. Cancer 64, 280-285
-
(1995)
Int. J. Cancer
, vol.64
, pp. 280-285
-
-
Bellacosa, A.1
De Feo, D.2
Godwin, A.K.3
Bell, D.W.4
Cheng, J.Q.5
Altomare, D.A.6
Wan, M.7
Dubeau, L.8
Scambia, G.9
Masciullo, V.10
Ferrandina, G.11
Benedetti Panici, P.12
Mancuso, S.13
Neri, G.14
Testa, J.R.15
-
6
-
-
0026667730
-
AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas
-
Cheng, J. Q., Godwin, A. K., Bellacosa, A., Taguchi, T., Franke, T. F., Hamilton, T. C., Tsichlis, P. N., and Testa, J. R. (1992) AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas Proc. Natl. Acad. Sci. U.S.A. 89, 9267-9271
-
(1992)
Proc. Natl. Acad. Sci. U.S.A.
, vol.89
, pp. 9267-9271
-
-
Cheng, J.Q.1
Godwin, A.K.2
Bellacosa, A.3
Taguchi, T.4
Franke, T.F.5
Hamilton, T.C.6
Tsichlis, P.N.7
Testa, J.R.8
-
7
-
-
0034604067
-
Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer
-
Yuan, Z. Q., Sun, M., Feldman, R. I., Wang, G., Ma, X., Jiang, C., Coppola, D., Nicosia, S. V., and Cheng, J. Q. (2000) Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer Oncogene 19, 2324-2330 (Pubitemid 30307208)
-
(2000)
Oncogene
, vol.19
, Issue.19
, pp. 2324-2330
-
-
Zeng, Q.Y.1
Sun, M.2
Feldman, R.I.3
Wang, G.4
Ma, X.-L.5
Jiang, C.6
Coppola, D.7
Nicosia, S.V.8
Cheng, J.Q.9
-
8
-
-
0035368548
-
Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBβ)
-
DOI 10.1126/science.292.5522.1728
-
Cho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., 3rd, Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., and Birnbaum, M. J. (2001) Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta) Science 292, 1728-1731 (Pubitemid 32506248)
-
(2001)
Science
, vol.292
, Issue.5522
, pp. 1728-1731
-
-
Cho, H.1
Mu, J.2
Kim, J.K.3
Thorvaldsen, J.L.4
Chu, Q.5
Crenshaw III, E.B.6
Kaestner, K.H.7
Bartolomei, M.S.8
Shulman, G.I.9
Birnbaum, M.J.10
-
9
-
-
0033515625
-
A human protein kinase Bgamma with regulatory phosphorylation sites in the activation loop and in the C-terminal hydrophobic domain
-
Brodbeck, D., Cron, P., and Hemmings, B. A. (1999) A human protein kinase Bgamma with regulatory phosphorylation sites in the activation loop and in the C-terminal hydrophobic domain J. Biol. Chem. 274, 9133-9136
-
(1999)
J. Biol. Chem.
, vol.274
, pp. 9133-9136
-
-
Brodbeck, D.1
Cron, P.2
Hemmings, B.A.3
-
10
-
-
23144449547
-
Essential role of protein kinase Bγ (PKBγ/Akt3) in postnatal brain developmental but not in glucose homeostasis
-
DOI 10.1242/dev.01864
-
Tschopp, O., Yang, Z. Z., Brodbeck, D., Dummler, B. A., Hemmings-Mieszczak, M., Watanabe, T., Michaelis, T., Frahm, J., and Hemmings, B. A. (2005) Essential role of protein kinase B gamma (PKB gamma/Akt3) in postnatal brain development but not in glucose homeostasis Development 132, 2943-2954 (Pubitemid 41086730)
-
(2005)
Development
, vol.132
, Issue.13
, pp. 2943-2954
-
-
Tschopp, O.1
Yang, Z.-Z.2
Brodbeck, D.3
Dummler, B.A.4
Hemmings-Mieszczak, M.5
Watanabe, T.6
Michaelis, T.7
Frahm, J.8
Hemmings, B.A.9
-
11
-
-
20344384859
-
Potent and selective inhibitors of Akt kinases slow the progress of tumors in vivo
-
DOI 10.1158/1535-7163.MCT-05-0005
-
Luo, Y., Shoemaker, A. R., Liu, X., Woods, K. W., Thomas, S. A., de Jong, R., Han, E. K., Li, T., Stoll, V. S., Powlas, J. A., Oleksijew, A., Mitten, M. J., Shi, Y., Guan, R., McGonigal, T. P., Klinghofer, V., Johnson, E. F., Leverson, J. D., Bouska, J. J., Mamo, M., Smith, R. A., Gramling-Evans, E. E., Zinker, B. A., Mika, A. K., Nguyen, P. T., Oltersdorf, T., Rosenberg, S. H., Li, Q., and Giranda, V. L. (2005) Potent and selective inhibitors of Akt kinases slow the progress of tumors in vivo Mol. Cancer Ther. 4, 977-986 (Pubitemid 40909080)
-
(2005)
Molecular Cancer Therapeutics
, vol.4
, Issue.6
, pp. 977-986
-
-
Luo, Y.1
Shoemaker, A.R.2
Liu, X.3
Woods, K.W.4
Thomas, S.A.5
De Jong, R.6
Han, E.K.7
Li, T.8
Stoll, V.S.9
Powlas, J.A.10
Oleksijew, A.11
Mitten, M.J.12
Shi, Y.13
Guan, R.14
McGonigal, T.P.15
Klinghofer, V.16
Johnson, E.F.17
Leverson, J.D.18
Bouska, J.J.19
Mamo, M.20
Smith, R.A.21
Gramling-Evans, E.E.22
Zinker, B.A.23
Mika, A.K.24
Nguyen, P.T.25
Oltersdorf, T.26
Rosenberg, S.H.27
Li, Q.28
Giranda, V.L.29
more..
-
12
-
-
67650337799
-
Inhibitor hijacking of Akt activation
-
Okuzumi, T., Fiedler, D., Zhang, C., Gray, D. C., Aizenstein, B., Hoffman, R., and Shokat, K. M. (2009) Inhibitor hijacking of Akt activation Nat. Chem. Biol. 5, 484-493
-
(2009)
Nat. Chem. Biol.
, vol.5
, pp. 484-493
-
-
Okuzumi, T.1
Fiedler, D.2
Zhang, C.3
Gray, D.C.4
Aizenstein, B.5
Hoffman, R.6
Shokat, K.M.7
-
13
-
-
52449089445
-
Identification of 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3 S)-3-piperidinylmethyl]oxy}-1 H -imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2- ol (GSK690693), a novel inhibitor of AKT kinase
-
Heerding, D. A., Rhodes, N., Leber, J. D., Clark, T. J., Keenan, R. M., Lafrance, L. V., Li, M., Safonov, I. G., Takata, D. T., Venslavsky, J. W., Yamashita, D. S., Choudhry, A. E., Copeland, R. A., Lai, Z., Schaber, M. D., Tummino, P. J., Strum, S. L., Wood, E. R., Duckett, D. R., Eberwein, D., Knick, V. B., Lansing, T. J., McConnell, R. T., Zhang, S., Minthorn, E. A., Concha, N. O., Warren, G. L., and Kumar, R. (2008) Identification of 4-(2-(4-amino-1,2,5- oxadiazol-3-yl)-1-ethyl-7-{[(3 S)-3-piperidinylmethyl]oxy}-1 H -imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a novel inhibitor of AKT kinase J. Med. Chem. 51, 5663-5679
-
(2008)
J. Med. Chem.
, vol.51
, pp. 5663-5679
-
-
Heerding, D.A.1
Rhodes, N.2
Leber, J.D.3
Clark, T.J.4
Keenan, R.M.5
Lafrance, L.V.6
Li, M.7
Safonov, I.G.8
Takata, D.T.9
Venslavsky, J.W.10
Yamashita, D.S.11
Choudhry, A.E.12
Copeland, R.A.13
Lai, Z.14
Schaber, M.D.15
Tummino, P.J.16
Strum, S.L.17
Wood, E.R.18
Duckett, D.R.19
Eberwein, D.20
Knick, V.B.21
Lansing, T.J.22
McConnell, R.T.23
Zhang, S.24
Minthorn, E.A.25
Concha, N.O.26
Warren, G.L.27
Kumar, R.28
more..
-
14
-
-
79951815611
-
Preclinical pharmacology, antitumor activity, and development of pharmacodynamic markers for the novel, potent AKT inhibitor CCT128930
-
Yap, T. A., Walton, M. I., Hunter, L. J., Valenti, M., de Haven Brandon, A., Eve, P. D., Ruddle, R., Heaton, S. P., Henley, A., Pickard, L., Vijayaraghavan, G., Caldwell, J. J., Thompson, N. T., Aherne, W., Raynaud, F. I., Eccles, S. A., Workman, P., Collins, I., and Garrett, M. D. (2011) Preclinical pharmacology, antitumor activity, and development of pharmacodynamic markers for the novel, potent AKT inhibitor CCT128930 Mol. Cancer Ther. 10, 360-371
-
(2011)
Mol. Cancer Ther.
, vol.10
, pp. 360-371
-
-
Yap, T.A.1
Walton, M.I.2
Hunter, L.J.3
Valenti, M.4
De Haven Brandon, A.5
Eve, P.D.6
Ruddle, R.7
Heaton, S.P.8
Henley, A.9
Pickard, L.10
Vijayaraghavan, G.11
Caldwell, J.J.12
Thompson, N.T.13
Aherne, W.14
Raynaud, F.I.15
Eccles, S.A.16
Workman, P.17
Collins, I.18
Garrett, M.D.19
-
15
-
-
77952234573
-
AT7867 is a potent and oral inhibitor of AKT and p70 S6 kinase that induces pharmacodynamic changes and inhibits human tumor xenograft growth
-
Grimshaw, K. M., Hunter, L. J., Yap, T. A., Heaton, S. P., Walton, M. I., Woodhead, S. J., Fazal, L., Reule, M., Davies, T. G., Seavers, L. C., Lock, V., Lyons, J. F., Thompson, N. T., Workman, P., and Garrett, M. D. (2010) AT7867 is a potent and oral inhibitor of AKT and p70 S6 kinase that induces pharmacodynamic changes and inhibits human tumor xenograft growth Mol. Cancer Ther. 9, 1100-1110
-
(2010)
Mol. Cancer Ther.
, vol.9
, pp. 1100-1110
-
-
Grimshaw, K.M.1
Hunter, L.J.2
Yap, T.A.3
Heaton, S.P.4
Walton, M.I.5
Woodhead, S.J.6
Fazal, L.7
Reule, M.8
Davies, T.G.9
Seavers, L.C.10
Lock, V.11
Lyons, J.F.12
Thompson, N.T.13
Workman, P.14
Garrett, M.D.15
-
16
-
-
2542547908
-
Perifosine, a novel alkylphospholipid, inhibits protein kinase B activation
-
Kondapaka, S. B., Singh, S. S., Dasmahapatra, G. P., Sausville, E. A., and Roy, K. K. (2003) Perifosine, a novel alkylphospholipid, inhibits protein kinase B activation Mol. Cancer Ther. 2, 1093-1103
-
(2003)
Mol. Cancer Ther.
, vol.2
, pp. 1093-1103
-
-
Kondapaka, S.B.1
Singh, S.S.2
Dasmahapatra, G.P.3
Sausville, E.A.4
Roy, K.K.5
-
17
-
-
11144222174
-
Inhibition of Akt kinase activity by a peptide spanning the βA strand of the proto-oncogene TCL1
-
DOI 10.1074/jbc.M403775200
-
Hiromura, M., Okada, F., Obata, T., Auguin, D., Shibata, T., Roumestand, C., and Noguchi, M. (2004) Inhibition of Akt kinase activity by a peptide spanning the betaA strand of the proto-oncogene TCL1 J. Biol. Chem. 279, 53407-53418 (Pubitemid 40051845)
-
(2004)
Journal of Biological Chemistry
, vol.279
, Issue.51
, pp. 53407-53418
-
-
Hiromura, M.1
Okada, F.2
Obata, T.3
Auguin, D.4
Shibata, T.5
Roumestand, C.6
Noguchi, M.7
-
18
-
-
77950906170
-
A small molecule inhibits Akt through direct binding to Akt and preventing Akt membrane translocation
-
Kim, D., Sun, M., He, L., Zhou, Q. H., Chen, J., Sun, X. M., Bepler, G., Sebti, S. M., and Cheng, J. Q. (2010) A small molecule inhibits Akt through direct binding to Akt and preventing Akt membrane translocation J. Biol. Chem. 285, 8383-8394
-
(2010)
J. Biol. Chem.
, vol.285
, pp. 8383-8394
-
-
Kim, D.1
Sun, M.2
He, L.3
Zhou, Q.H.4
Chen, J.5
Sun, X.M.6
Bepler, G.7
Sebti, S.M.8
Cheng, J.Q.9
-
19
-
-
3042743988
-
Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt
-
DOI 10.1158/0008-5472.CAN-04-0343
-
Yang, L., Dan, H. C., Sun, M., Liu, Q., Sun, X. M., Feldman, R. I., Hamilton, A. D., Polokoff, M., Nicosia, S. V., Herlyn, M., Sebti, S. M., and Cheng, J. Q. (2004) Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt Cancer Res. 64, 4394-4399 (Pubitemid 38856907)
-
(2004)
Cancer Research
, vol.64
, Issue.13
, pp. 4394-4399
-
-
Yang, L.1
Dan, H.C.2
Sun, M.3
Liu, Q.4
Sun, X.-M.5
Feldman, R.I.6
Hamilton, A.D.7
Polokoff, M.8
Nicosia, S.V.9
Herlyn, M.10
Sebti, S.M.11
Cheng, J.Q.12
-
20
-
-
77957833800
-
The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane
-
Berndt, N., Yang, H., Trinczek, B., Betzi, S., Zhang, Z., Wu, B., Lawrence, N. J., Pellecchia, M., Schonbrunn, E., Cheng, J. Q., and Sebti, S. M. (2010) The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane Cell Death Differ. 17, 1795-1804
-
(2010)
Cell Death Differ.
, vol.17
, pp. 1795-1804
-
-
Berndt, N.1
Yang, H.2
Trinczek, B.3
Betzi, S.4
Zhang, Z.5
Wu, B.6
Lawrence, N.J.7
Pellecchia, M.8
Schonbrunn, E.9
Cheng, J.Q.10
Sebti, S.M.11
-
21
-
-
78650546282
-
Small molecule inhibition of phosphatidylinositol-3,4,5-triphosphate (PIP3) binding to pleckstrin homology domains
-
Miao, B., Skidan, I., Yang, J., Lugovskoy, A., Reibarkh, M., Long, K., Brazell, T., Durugkar, K. A., Maki, J., Ramana, C. V., Schaffhausen, B., Wagner, G., Torchilin, V., Yuan, J., and Degterev, A. (2010) Small molecule inhibition of phosphatidylinositol-3,4,5-triphosphate (PIP3) binding to pleckstrin homology domains Proc. Natl. Acad. Sci. U.S.A. 107, 20126-20131
-
(2010)
Proc. Natl. Acad. Sci. U.S.A.
, vol.107
, pp. 20126-20131
-
-
Miao, B.1
Skidan, I.2
Yang, J.3
Lugovskoy, A.4
Reibarkh, M.5
Long, K.6
Brazell, T.7
Durugkar, K.A.8
Maki, J.9
Ramana, C.V.10
Schaffhausen, B.11
Wagner, G.12
Torchilin, V.13
Yuan, J.14
Degterev, A.15
-
22
-
-
84908061571
-
MK-2206: A potent oral allosteric AKT inhibitor
-
Abstract DDT01-1
-
Yan, L. (2009) MK-2206: A potent oral allosteric AKT inhibitor, AACR Meeting Abstracts 2009, Abstract DDT01-1.
-
(2009)
AACR Meeting Abstracts 2009
-
-
Yan, L.1
-
23
-
-
79953852883
-
The Akt-specific inhibitor MK2206 selectively inhibits thyroid cancer cells harboring mutations that can activate the PI3K/Akt pathway
-
Liu, R., Liu, D., Trink, E., Bojdani, E., Ning, G., and Xing, M. (2011) The Akt-specific inhibitor MK2206 selectively inhibits thyroid cancer cells harboring mutations that can activate the PI3K/Akt pathway J. Clin. Endocrinol. Metab. 96, E577-585
-
(2011)
J. Clin. Endocrinol. Metab.
, vol.96
, pp. 577-585
-
-
Liu, R.1
Liu, D.2
Trink, E.3
Bojdani, E.4
Ning, G.5
Xing, M.6
-
24
-
-
19944431003
-
Allosteric Akt (PKB) inhibitors: Discovery and SAR of isozyme selective inhibitors
-
DOI 10.1016/j.bmcl.2004.11.011, PII S0960894X04013435
-
Lindsley, C. W., Zhao, Z., Leister, W. H., Robinson, R. G., Barnett, S. F., Defeo-Jones, D., Jones, R. E., Hartman, G. D., Huff, J. R., Huber, H. E., and Duggan, M. E. (2005) Allosteric Akt (PKB) inhibitors: discovery and SAR of isozyme selective inhibitors Bioorg. Med. Chem. Lett. 15, 761-764 (Pubitemid 40143162)
-
(2005)
Bioorganic and Medicinal Chemistry Letters
, vol.15
, Issue.3
, pp. 761-764
-
-
Lindsley, C.W.1
Zhao, Z.2
Leister, W.H.3
Robinson, R.G.4
Barnett, S.F.5
Defeo-Jones, D.6
Jones, R.E.7
Hartman, G.D.8
Huff, J.R.9
Huber, H.E.10
Duggan, M.E.11
-
25
-
-
78149464882
-
Akti-1/2, an allosteric inhibitor of Akt 1 and 2, efficiently inhibits CaMKIalpha activity and aryl hydrocarbon receptor pathway
-
Gilot, D., Giudicelli, F., Lagadic-Gossmann, D., and Fardel, O. (2010) Akti-1/2, an allosteric inhibitor of Akt 1 and 2, efficiently inhibits CaMKIalpha activity and aryl hydrocarbon receptor pathway Chem. Biol. Interact. 188, 546-552
-
(2010)
Chem. Biol. Interact.
, vol.188
, pp. 546-552
-
-
Gilot, D.1
Giudicelli, F.2
Lagadic-Gossmann, D.3
Fardel, O.4
-
26
-
-
77958576132
-
Crystal structure of human AKT1 with an allosteric inhibitor reveals a new mode of kinase inhibition
-
Wu, W. I., Voegtli, W. C., Sturgis, H. L., Dizon, F. P., Vigers, G. P., and Brandhuber, B. J. (2010) Crystal structure of human AKT1 with an allosteric inhibitor reveals a new mode of kinase inhibition PLoS One 5, e12913
-
(2010)
PLoS One
, vol.5
, pp. 12913
-
-
Wu, W.I.1
Voegtli, W.C.2
Sturgis, H.L.3
Dizon, F.P.4
Vigers, G.P.5
Brandhuber, B.J.6
-
27
-
-
34247484461
-
A novel substrate mimetic inhibitor of PKB/Akt inhibits prostate cancer tumor growth in mice by blocking the PKB pathway
-
DOI 10.1021/bi061928s
-
Litman, P., Ohne, O., Ben-Yaakov, S., Shemesh-Darvish, L., Yechezkel, T., Salitra, Y., Rubnov, S., Cohen, I., Senderowitz, H., Kidron, D., Livnah, O., Levitzki, A., and Livnah, N. (2007) A novel substrate mimetic inhibitor of PKB/Akt inhibits prostate cancer tumor growth in mice by blocking the PKB pathway Biochemistry 46, 4716-4724 (Pubitemid 46651194)
-
(2007)
Biochemistry
, vol.46
, Issue.16
, pp. 4716-4724
-
-
Litman, P.1
Ohne, O.2
Ben-Yaakov, S.3
Shemesh-Darvish, L.4
Yechezkel, T.5
Salitra, Y.6
Rubnov, S.7
Cohen, I.8
Senderowitz, H.9
Kidron, D.10
Livnah, O.11
Levitzki, A.12
Livnah, N.13
-
28
-
-
0034680838
-
Peptide and protein library screening defines optimal substrate motifs for AKT/PKB
-
Obata, T., Yaffe, M. B., Leparc, G. G., Piro, E. T., Maegawa, H., Kashiwagi, A., Kikkawa, R., and Cantley, L. C. (2000) Peptide and protein library screening defines optimal substrate motifs for AKT/PKB J. Biol. Chem. 275, 36108-36115
-
(2000)
J. Biol. Chem.
, vol.275
, pp. 36108-36115
-
-
Obata, T.1
Yaffe, M.B.2
Leparc, G.G.3
Piro, E.T.4
Maegawa, H.5
Kashiwagi, A.6
Kikkawa, R.7
Cantley, L.C.8
-
29
-
-
10744220705
-
Pseudosubstrate Peptides Inhibit Akt and Induce Cell Growth Inhibition
-
DOI 10.1021/bi034515p
-
Luo, Y., Smith, R. A., Guan, R., Liu, X., Klinghofer, V., Shen, J., Hutchins, C., Richardson, P., Holzman, T., Rosenberg, S. H., and Giranda, V. L. (2004) Pseudosubstrate peptides inhibit Akt and induce cell growth inhibition Biochemistry 43, 1254-1263 (Pubitemid 38176523)
-
(2004)
Biochemistry
, vol.43
, Issue.5
, pp. 1254-1263
-
-
Luo, Y.1
Smith, R.A.2
Guan, R.3
Liu, X.4
Klinghofer, V.5
Shen, J.6
Hutchins, C.7
Richardson, P.8
Holzman, T.9
Rosenberg, S.H.10
Giranda, V.L.11
-
30
-
-
16844381988
-
Proapoptotic activity of cell-permeable anti-Akt single-chain antibodies
-
DOI 10.1158/0008-5472.CAN-04-2898
-
Shin, I., Edl, J., Biswas, S., Lin, P. C., Mernaugh, R., and Arteaga, C. L. (2005) Proapoptotic activity of cell-permeable anti-Akt single-chain antibodies Cancer Res. 65, 2815-2824 (Pubitemid 40490084)
-
(2005)
Cancer Research
, vol.65
, Issue.7
, pp. 2815-2824
-
-
Shin, I.1
Edl, J.2
Biswas, S.3
Lin, P.C.4
Mernaugh, R.5
Arteaga, C.L.6
-
31
-
-
61849181403
-
AKT inhibitor, GSK690693, induces growth inhibition and apoptosis in acute lymphoblastic leukemia cell lines
-
Levy, D. S., Kahana, J. A., and Kumar, R. (2009) AKT inhibitor, GSK690693, induces growth inhibition and apoptosis in acute lymphoblastic leukemia cell lines Blood 113, 1723-1729
-
(2009)
Blood
, vol.113
, pp. 1723-1729
-
-
Levy, D.S.1
Kahana, J.A.2
Kumar, R.3
-
32
-
-
33646044708
-
A highly flexible tRNA acylation method for non-natural polypeptide synthesis
-
Murakami, H., Ohta, A., Ashigai, H., and Suga, H. (2006) A highly flexible tRNA acylation method for non-natural polypeptide synthesis Nat. Methods 3, 357-359
-
(2006)
Nat. Methods
, vol.3
, pp. 357-359
-
-
Murakami, H.1
Ohta, A.2
Ashigai, H.3
Suga, H.4
-
33
-
-
37149000703
-
Synthesis of Polyester by Means of Genetic Code Reprogramming
-
DOI 10.1016/j.chembiol.2007.10.015, PII S1074552107003705
-
Ohta, A., Murakami, H., Higashimura, E., and Suga, H. (2007) Synthesis of polyester by means of genetic code reprogramming Chem. Biol. 14, 1315-1322 (Pubitemid 350257006)
-
(2007)
Chemistry and Biology
, vol.14
, Issue.12
, pp. 1315-1322
-
-
Ohta, A.1
Murakami, H.2
Higashimura, E.3
Suga, H.4
-
34
-
-
38349062552
-
Messenger RNA-programmed incorporation of multiple N-methyl-amino acids into linear and cyclic peptides
-
Kawakami, T., Murakami, H., and Suga, H. (2008) Messenger RNA-programmed incorporation of multiple N-methyl-amino acids into linear and cyclic peptides Chem. Biol. 15, 32-42
-
(2008)
Chem. Biol.
, vol.15
, pp. 32-42
-
-
Kawakami, T.1
Murakami, H.2
Suga, H.3
-
35
-
-
58049219079
-
Ribosomal synthesis of polypeptoids and peptoid-peptide hybrids
-
Kawakami, T., Murakami, H., and Suga, H. (2008) Ribosomal synthesis of polypeptoids and peptoid-peptide hybrids J. Am. Chem. Soc. 130, 16861-16863
-
(2008)
J. Am. Chem. Soc.
, vol.130
, pp. 16861-16863
-
-
Kawakami, T.1
Murakami, H.2
Suga, H.3
-
36
-
-
38349027623
-
Reprogramming the translation initiation for the synthesis of physiologically stable cyclic peptides
-
DOI 10.1021/cb700233t
-
Goto, Y., Ohta, A., Sako, Y., Yamagishi, Y., Murakami, H., and Suga, H. (2008) Reprogramming the translation initiation for the synthesis of physiologically stable cyclic peptides ACS Chem. Biol. 3, 120-129 (Pubitemid 351419412)
-
(2008)
ACS Chemical Biology
, vol.3
, Issue.2
, pp. 120-129
-
-
Goto, Y.1
Ohta, A.2
Sako, Y.3
Yamagishi, Y.4
Murakami, H.5
Suga, H.6
-
37
-
-
79958158209
-
Flexizymes for genetic code reprogramming
-
Goto, Y., Katoh, T., and Suga, H. (2011) Flexizymes for genetic code reprogramming Nat. Protoc. 6, 779-790
-
(2011)
Nat. Protoc.
, vol.6
, pp. 779-790
-
-
Goto, Y.1
Katoh, T.2
Suga, H.3
-
38
-
-
0031559943
-
In vitro virus: Bonding of mRNA bearing puromycin at the 3'-terminal end to the C-terminal end of its encoded protein on the ribosome in vitro
-
DOI 10.1016/S0014-5793(97)01026-0, PII S0014579397010260
-
Nemoto, N., Miyamoto-Sato, E., Husimi, Y., and Yanagawa, H. (1997) In vitro virus: bonding of mRNA bearing puromycin at the 3′-terminal end to the C-terminal end of its encoded protein on the ribosome in vitro FEBS Lett. 414, 405-408 (Pubitemid 27389405)
-
(1997)
FEBS Letters
, vol.414
, Issue.2
, pp. 405-408
-
-
Nemoto, N.1
Miyamoto-Sato, E.2
Husimi, Y.3
Yanagawa, H.4
-
40
-
-
34548755067
-
Assay of protein kinases using radiolabeled ATP: A protocol
-
Hastie, C. J., McLauchlan, H. J., and Cohen, P. (2006) Assay of protein kinases using radiolabeled ATP: a protocol Nat. Protoc. 1, 968-971
-
(2006)
Nat. Protoc.
, vol.1
, pp. 968-971
-
-
Hastie, C.J.1
McLauchlan, H.J.2
Cohen, P.3
-
41
-
-
0029587224
-
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
-
DOI 10.1038/378785a0
-
Cross, D. A., Alessi, D. R., Cohen, P., Andjelkovich, M., and Hemmings, B. A. (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B Nature 378, 785-789 (Pubitemid 26004411)
-
(1995)
Nature
, vol.378
, Issue.6559
, pp. 785-789
-
-
Cross, D.A.E.1
Alessi, D.R.2
Cohen, P.3
Andjelkovich, M.4
Hemmings, B.A.5
-
42
-
-
18744373865
-
Crystal structure of an activated Akt/Protein Kinase B ternary complex with GSK3-peptide and AMP-PNP
-
DOI 10.1038/nsb870
-
Yang, J., Cron, P., Good, V. M., Thompson, V., Hemmings, B. A., and Barford, D. (2002) Crystal structure of an activated Akt/protein kinase B ternary complex with GSK3-peptide and AMP-PNP Nat. Struct. Biol. 9, 940-944 (Pubitemid 35417064)
-
(2002)
Nature Structural Biology
, vol.9
, Issue.12
, pp. 940-944
-
-
Yang, J.1
Cron, P.2
Good, V.M.3
Thompson, V.4
Hemmings, B.A.5
Barford, D.6
|